Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Was Conducted With Participants Divided Into Three Groups: RETI, VR, and a Control Group. The RETI Group Visualized Successful FT Scenarios, the VR Group Practiced FTs in a Simulated Game Environment, and the Control Group Continued Regular Practice. Measurements Were Taken Before and After the Interventions Using Standard FT Performance Tests and the FTSE Questionnaire. Statistical Analyses, Including Mixed Factorial ANOVA, Were Performed to Evaluate the Effectiveness of the Interventions.

NCT06565533 is registered in ClinicalTrials.gov with Wu Jiarun as lead sponsor.

NCT NCT06565533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Was Conducted With Participants Divided Into Three Groups: RETI, VR, and a Control Group. The RETI Group Visualized Successful FT Scenarios, the VR Group Practiced FTs in a Simulated Game Environment, and the Control Group Continued Regular Practice. Measurements Were Taken Before and After the Interventions Using Standard FT Performance Tests and the FTSE Questionnaire. Statistical Analyses, Including Mixed Factorial ANOVA, Were Performed to Evaluate the Effectiveness of the Interventions.
Lead sponsor
Wu Jiarun
Phase
Not applicable
Overall status
Completed
Start date
November 5, 2023
Completion date
June 10, 2024
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ftse, reti, vr